Vitae Enim Vitae Scientific, Inc.
FDA 503B outsourcing facility
San Diego, California
Key Takeaways
- FDA-registered 503B outsourcing facility since 2024
- Sterile compounding from bulk substances: No
- Not yet inspected by the FDA
- 4 FDA drug recalls on record (2022)
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- January 2, 2024
- Most recent registration
- December 29, 2025
- Compounds sterile drugs from bulk substances
- No
- Last FDA inspection
- Not yet inspected
Vitae Enim Vitae Scientific, Inc. has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
FDA recall history
Vitae Enim Vitae Scientific, Inc. has 4 FDA drug recalls on record in 2022, based on the FDA enforcement database. Breakdown: 4 Class II.
Recall reasons on record include lack of assurance of sterility: deviations from current good manufacturing practices.
| Date | Class | Product | Reason |
|---|---|---|---|
| March 2022 | Class II | TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vials per box, Rx only, Manufactured for Cameron Pharma | Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. |
| March 2022 | Class II | PHENOBARBITAL Sodium Injection, USP, 65mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-415-25) and b) 3 x 1 mL Vials per box (NDC 4 | Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. |
| March 2022 | Class II | PHENOBARBITAL Sodium Injection, USP, 130 mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-416-25) and b) 3 x 1mL Vials per box (NDC | Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. |
| March 2022 | Class II | PAPAVERINE HYDROCHLORIDE Injection, USP, 60 mg/2mL (30 mg/mL), packaged as a) 25 x 2mL Single Use Vials per box (NDC 72516-024-25) and b) 10 | Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. |
FDA recall classes signal severity, not intent: Class I means a reasonable probability of serious harm, Class II a temporary or reversible risk, Class III a violation unlikely to cause harm. Sterile compounders routinely recall lots as a precaution. FDA definitions.
Compounded peptides and GLP-1s
Vitae Enim Vitae Scientific, Inc. has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
3030 Bunker Hill St Ste 203, San Diego, CA 92109-5754
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Boris Gites, 858-222-0746. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Vitae Enim Vitae Scientific, Inc. with the California State Board of Pharmacy.
503B facilities in California
California has 7 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in California.
Frequently asked questions
Is Vitae Enim Vitae Scientific, Inc. registered with the FDA?
Yes. Vitae Enim Vitae Scientific, Inc. is a registered 503B outsourcing facility, first registered with the FDA on January 2, 2024 and most recently registered on December 29, 2025.
Has Vitae Enim Vitae Scientific, Inc. been inspected by the FDA?
Vitae Enim Vitae Scientific, Inc. has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has Vitae Enim Vitae Scientific, Inc. had any FDA drug recalls?
Vitae Enim Vitae Scientific, Inc. has 4 FDA drug recalls on record (2022) in the FDA enforcement database.
What does Vitae Enim Vitae Scientific, Inc. compound?
Vitae Enim Vitae Scientific, Inc. has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Vitae Enim Vitae Scientific, Inc. located?
Vitae Enim Vitae Scientific, Inc. is located in San Diego, California (3030 Bunker Hill St Ste 203).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026. Recall history from the FDA openFDA drug enforcement database, retrieved June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Vitae Enim Vitae Scientific, Inc.. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.